Abstract

NLRP3 controls the secretion of inflammatory cytokines IL-1β/18 and pyroptosis by assembling the inflammasome. Upon coordinated priming and activation stimuli, NLRP3 recruits NEK7 within hetero-oligomers that nucleate ASC and caspase-1 filaments, but the apical molecular mechanisms underlying inflammasome assembly remain elusive. Here we show that NEK7 recruitment to NLRP3 is controlled by the phosphorylation status of NLRP3 S803 located within the interaction surface, in which NLRP3 S803 is phosphorylated upon priming and later dephosphorylated upon activation. Phosphomimetic substitutions of S803 abolish NEK7 recruitment and inflammasome activity in macrophages in vitro and in vivo. In addition, NLRP3-NEK7 binding is also essential for NLRP3 deubiquitination by BRCC3 and subsequently inflammasome assembly, with NLRP3 phosphomimetic mutants showing enhanced ubiquitination and degradation than wildtype NLRP3. Finally, we identify CSNK1A1 as the kinase targeting NLRP3 S803. Our findings thus reveal NLRP3 S803 phosphorylation status as a druggable apical molecular mechanism controlling inflammasome assembly.

Nlrp3 inflammasome activation requires Nek7 recruitment to drive ASC speck formation. Here the authors show how Nlrp3 phosphorylation events control this Nek7 recruitment.

Details

Title
NLRP3 phosphorylation in its LRR domain critically regulates inflammasome assembly
Author
Niu Tingting 1   VIAFID ORCID Logo  ; De Rosny Charlotte 2   VIAFID ORCID Logo  ; Chautard Séverine 2   VIAFID ORCID Logo  ; Rey Amaury 2   VIAFID ORCID Logo  ; Danish, Patoli 2 ; Groslambert Marine 2 ; Cosson Camille 2   VIAFID ORCID Logo  ; Lagrange Brice 2 ; Zhang, Zhirong 3 ; Visvikis Orane 4 ; Hacot Sabine 5 ; Hologne Maggy 6   VIAFID ORCID Logo  ; Walker, Olivier 6   VIAFID ORCID Logo  ; Wong Jeimin 7   VIAFID ORCID Logo  ; Wang, Ping 8 ; Ricci Roméo 3 ; Henry, Thomas 2   VIAFID ORCID Logo  ; Boyer, Laurent 4   VIAFID ORCID Logo  ; Petrilli Virginie 5   VIAFID ORCID Logo  ; Py, Bénédicte F 2   VIAFID ORCID Logo 

 Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, CIRI, Centre International de Recherche en Infectiologie, Lyon, France (GRID:grid.15140.31) (ISNI:0000 0001 2175 9188); East China Normal University, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, Shanghai, China (GRID:grid.22069.3f) (ISNI:0000 0004 0369 6365) 
 Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, CIRI, Centre International de Recherche en Infectiologie, Lyon, France (GRID:grid.15140.31) (ISNI:0000 0001 2175 9188) 
 CNRS, UMR7104, Inserm, U964, Université de Strasbourg, IGBMC, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France (GRID:grid.420255.4) (ISNI:0000 0004 0638 2716) 
 Université Côte d’Azur, Inserm, C3M, Nice, France (GRID:grid.462370.4) (ISNI:0000 0004 0620 5402) 
 INSERM U1052, CNRS UMR5286, Université de Lyon, Université Lyon 1, Centre Léon Bérard, CRCL, Centre de Recherche en Cancérologie de Lyon, Lyon, France (GRID:grid.462282.8) (ISNI:0000 0004 0384 0005) 
 Univ Lyon, CNRS, CNRS UMR5280, Université Claude Bernard Lyon 1, Institut des Sciences Analytiques (ISA), Villeurbanne, France (GRID:grid.7849.2) (ISNI:0000 0001 2150 7757) 
 East China Normal University, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, Shanghai, China (GRID:grid.22069.3f) (ISNI:0000 0004 0369 6365) 
 Tongji University, Shanghai Tenth People’s Hospital of Tongji University, Tongji Cancer Center, School of Medicine, Shanghai, China (GRID:grid.24516.34) (ISNI:0000000123704535) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2579464225
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.